Literature DB >> 28342268

The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture's disease.

Li-Jun Xie1,2, Zhao Cui1, Fang-Jin Chen3, Zhi-Yong Pei4, Shui-Yi Hu1, Qiu-Hua Gu1, Xiao-Yu Jia1, Li Zhu1, Xu-Jie Zhou1, Hong Zhang1, Yun-Hua Liao2, Lu-Hua Lai3, Billy G Hudson5, Ming-Hui Zhao1,6.   

Abstract

Goodpasture's disease is closely associated with HLA, particularly DRB1*1501. Other susceptible or protective HLA alleles are not clearly elucidated. The presentation models of epitopes by susceptible HLA alleles are also unclear. We genotyped 140 Chinese patients and 599 controls for four-digit HLA II genes, and extracted the encoding sequences from the IMGT/HLA database. T-cell epitopes of α3(IV)NC1 were predicted and the structures of DR molecule-peptide-T-cell receptor were constructed. We confirmed DRB1*1501 (OR = 4·6, P = 5·7 × 10-28 ) to be a risk allele for Goodpasture's disease. Arginine at position 13 (ARG13) (OR = 4·0, P = 1·0 × 10-17 ) and proline at position 11 (PRO11) (OR = 4·0, P = 2·0 × 10-17 ) on DRβ1, encoded by DRB1*1501, were associated with disease susceptibility. α134-148 (HGWISLWKGFSFIMF) was predicted as a T-cell epitope presented by DRB1*1501. Isoleucine137 , tryptophan140 , glycine142 , phenylalanine143 and phenylalanine145 , were presented in peptide-binding pockets 1, 4, 6, 7 and 9 of DR2b, respectively. ARG13 in pocket 4 interacts with tryptophan140 and forms a hydrogen bond. In conclusion, we propose a mechanism for DRB1*1501 susceptibility for Goodpasture's disease through encoding ARG13 and PRO11 on MHC-DRβ1 chain and presenting T-cell epitope, α134-148 , with five critical residues.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990HLAzzm321990; zzm321990MHCzzm321990; Goodpasture's disease; anti- glomerular basement membrane disease; epitope

Mesh:

Substances:

Year:  2017        PMID: 28342268      PMCID: PMC5506429          DOI: 10.1111/imm.12736

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

Review 1.  Immunotherapeutic strategies directed at the trimolecular complex.

Authors:  A Gaur; C G Fathman
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

2.  Polymorphism, recombination, and linkage disequilibrium within the HLA class II region.

Authors:  A B Begovich; G R McClure; V C Suraj; R C Helmuth; N Fildes; T L Bugawan; H A Erlich; W Klitz
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

3.  Migration of a novel DQA1* allele (DQA1*0502) from African origin to North and South America.

Authors:  P A Zimmerman; P M Phadke; A Lee; L H Elson; E Aruajo; R Guderian; T B Nutman
Journal:  Hum Immunol       Date:  1995-03       Impact factor: 2.850

4.  The HLA-DRβ1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations.

Authors:  Kwangwoo Kim; So-Young Bang; Hye-Soon Lee; Yukinori Okada; Buhm Han; Woei-Yuh Saw; Yik-Ying Teo; Sang-Cheol Bae
Journal:  Nat Commun       Date:  2014-12-23       Impact factor: 14.919

5.  Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury.

Authors:  Xiao-yu Jia; Zhao Cui; Rui Yang; Shui-yi Hu; Ming-hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-29       Impact factor: 8.237

6.  Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes.

Authors:  M Fisher; C D Pusey; R W Vaughan; A J Rees
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

7.  The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease.

Authors:  Rui Yang; Zhao Cui; Juan Zhao; Ming-Hui Zhao
Journal:  Clin Immunol       Date:  2009-08-04       Impact factor: 3.969

Review 8.  Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.

Authors:  Joshua D Ooi; Stephen R Holdsworth; A Richard Kitching
Journal:  J Autoimmun       Date:  2008-05-27       Impact factor: 7.094

9.  DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).

Authors:  Nathali Kaushansky; Daniel M Altmann; Chella S David; Hans Lassmann; Avraham Ben-Nun
Journal:  J Neuroinflammation       Date:  2012-02-08       Impact factor: 8.322

10.  Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Authors:  Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more
  5 in total

1.  Experimental Antiglomerular Basement Membrane GN Induced by a Peptide from Actinomyces.

Authors:  Qiu-Hua Gu; Megan Huynh; Yue Shi; Xiao-Yu Jia; Jie-Jian Luo; Tai-Jiao Jiang; Zhao Cui; Joshua D Ooi; A Richard Kitching; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2020-06       Impact factor: 10.121

Review 2.  Goodpasture's autoimmune disease - A collagen IV disorder.

Authors:  Vadim Pedchenko; A Richard Kitching; Billy G Hudson
Journal:  Matrix Biol       Date:  2018-05-12       Impact factor: 11.583

3.  A Modified Peptide Derived from Goodpasture Autoantigen Arrested and Attenuated Kidney Injuries in a Rat Model of Anti-GBM Glomerulonephritis.

Authors:  Yue Shi; Xiao-Yu Jia; Qiu-Hua Gu; Miao Wang; Zhao Cui; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2019-10-30       Impact factor: 10.121

4.  Collagen IVα345 dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture's and Alport diseases.

Authors:  Elena N Pokidysheva; Harald Seeger; Vadim Pedchenko; Sergei Chetyrkin; Carsten Bergmann; Dale Abrahamson; Zhao Wei Cui; Eric Delpire; Fernando C Fervenza; Aaron L Fidler; Agnes B Fogo; Ariana Gaspert; Maik Grohmann; Oliver Gross; George Haddad; Raymond C Harris; Clifford Kashtan; A Richard Kitching; Johan M Lorenzen; Stephen McAdoo; Charles D Pusey; Marten Segelmark; Alicia Simmons; Paul A Voziyan; Timo Wagner; Rudolf P Wüthrich; Ming-Hui Zhao; Sergei P Boudko; Andreas D Kistler; Billy G Hudson
Journal:  J Biol Chem       Date:  2021-03-26       Impact factor: 5.486

Review 5.  Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?

Authors:  Inga Koneczny; Vuslat Yilmaz; Konstantinos Lazaridis; John Tzartos; Tobias L Lenz; Socrates Tzartos; Erdem Tüzün; Frank Leypoldt
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.